Teladoc (TDOC) PT Raised to $68 at Oppenheimer

Go back to Teladoc (TDOC) PT Raised to $68 at Oppenheimer

Teladoc (TDOC) PT Raised to $86 at Chardan Capital Markets

August 3, 2018 6:39 AM EDT

Chardan Capital Markets raised its price target on Teladoc (NYSE: TDOC) to $86.00 (from $73.00) while maintaining a Buy rating.

Analyst Steven Wardell commented, "After market close on Wed., TDOC reported revenue and earnings that beat "consensus, and raised its 2018 guide. TDOCs... More

Teladoc (TDOC) PT Raised to $52 at Cantor Fitzgerald Following 2Q

August 2, 2018 8:21 AM EDT

Cantor Fitzgerald raised its price target on Teladoc (NYSE: TDOC) to $52.00 (from $50.00) while maintaining a Neutral rating following the company's 2Q release. Revenue was $94.6 million vs. consensus of $92M. U.S. paid visits grew 41%.

Given the strong growth and including Advance Medical, TDOC... More

Teladoc (TDOC) PT Raised to $77 at Piper Jaffray Following 2Q Report

August 2, 2018 7:13 AM EDT

Piper Jaffray raised its price target on Teladoc (NYSE: TDOC) to $77.00 (from $55.00) while maintaining an Overweight rating following the company's 2Q earnings report. Total revenue of $94.6M was up 112% on an absolute basis and 39% organically, and beat Consensus estimates of $91.9M. EBITDA of... More

Teladoc (TDOC) PT Raised to $74 at KeyBanc

August 2, 2018 5:12 AM EDT

KeyBanc raised its price target on Teladoc (NYSE: TDOC) to $74.00 (from $70.00) while maintaining a Overweight rating.

... More

Teladoc (TDOC) Misses Q2 EPS by 3c, Revenues Beat; Guides Revs Above

August 1, 2018 4:07 PM EDT

Teladoc (NYSE: TDOC) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $94.6 million versus the consensus estimate of $92.37 million.

GUIDANCE:

Teladoc sees Q3 2018 revenue of $106-108 million, versus the consensus of $105.1... More